About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clinical Trials in Miami | 5,521 Studies Near You | Clareo Health

Clinical Trials LocationsMiami

Clinical Trials in Miami

Discover 5,521 clinical trials near Miami, Florida. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Filters

Sort by

Status

Recruiting(Enrolling)

Not yet recruiting

Active, not recruiting

Enrolling by invitation(Enrolling)

Completed

Terminated

Phase

Early Phase 1

Phase 1

Phase 1/Phase 2

Phase 2

Phase 2/Phase 3

Phase 3

Phase 4

Not Applicable

Eligibility

Accepts healthy volunteers

Showing 2701-2720 of 5,521 trials

COMPLETEDNA< 1 mile

Percutaneous Endovascular Aneurysm Repair (PEVAR) Trial

NCT01070069

To determine the safety and effectiveness of PEVAR.

Abdominal Aortic Aneurysm

Endologix192 participantsStarted Apr 2010

Loma Linda, California, United States • San Diego, California, United States • Fort Lauderdale, Florida, United States +17 more locations

COMPLETEDPhase 2/3< 1 mile

A Study of Granexin® Gel for the Reduction of Scar Formation in Surgical Wounds Following Bilateral Anchor Incision Breast Surgery

NCT04331080

The purpose of this study is to evaluate effectiveness of Granexin® gel in reducing scar formation in surgical incisional wounds.

MammoplastyScarringScar+1 more

Xequel Bio, Inc.184 participantsStarted Jul 2020

Los Angeles, California, United States • Pasadena, California, United States • Doral, Florida, United States +8 more locations

Find Trials by Condition in Miami

Breast Cancerin Miami Lung Cancerin Miami Prostate Cancerin Miami Colorectal Cancerin Miami Melanomain Miami Leukemiain Miami Lymphomain Miami Pancreatic Cancerin Miami Ovarian Cancerin Miami Brain Cancerin Miami Diabetesin Miami

Data from ClinicalTrials.govTerms

COMPLETEDPhase 3< 1 mile

Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ

NCT00003857

RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using tamoxifen may fight breast cancer by blocking the uptake of estrogen by the tumor cells. It is not yet known if radiation therapy is more effective than observation, with or without tamoxifen, in treating ductal carcinoma in situ. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with that of observation, with or without tamoxifen, in treating women who have ductal carcinoma in situ.

Radiation Therapy Oncology Group636 participantsStarted Dec 1999

Mobile, Alabama, United States • Fairbanks, Alaska, United States • Phoenix, Arizona, United States +366 more locations

UNKNOWNPhase 2< 1 mile

Combination Chemotherapy With or Without Hypofractionated Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer

NCT02839343

This randomized phase II trial studies how well combination chemotherapy (mFOLFIRINOX) with or without hypofractionated radiation therapy before surgery works in patients with pancreatic cancer that can be removed by surgery. Drugs used in combination chemotherapy, such as oxaliplatin, leucovorin calcium, fluorouracil, and irinotecan hydrochloride, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects. It is not yet known if combination chemotherapy is more effective with or without hypofractionated radiation therapy before surgery in treating patients with pancreatic cancer.

Pancreatic AdenocarcinomaBorderline Resectable Adenocarcinoma of the Head of the Pancrease

Alliance for Clinical Trials in Oncology126 participantsStarted Dec 2016

Mobile, Alabama, United States • Mobile, Alabama, United States • Mobile, Alabama, United States +152 more locations

UNKNOWNNA< 1 mile

Intervention to Reduce Serious Mental Illness and Suicide Stigma Among Medical Students

NCT05325320

The team aims to develop and test the efficacy of a serious mental illness (SMI) and suicide ideation and attempt (SIA) stigma reduction intervention for medical students. The team expects that after intervention exposure, relative to control group, participants in the experimental condition will manifest more favorable change in knowledge, attitudes, and behaviors.

StigmatizationClinical Competence

Ponce Medical School Foundation, Inc.126 participantsStarted Apr 2022

Miami, Florida, United States • Ponce, Puerto Rico

COMPLETEDNA< 1 mile

Vestibular Testing: Consistency and Effects Over Time

NCT03182868

The goal of this study is to test the consistency and repeatability of a portable goggle system for testing optokinetic, ocular, and reaction time. The study examines the day to day consistency, time of day and learning effects as well as any secondary motion sickness.

University of Miami78 participantsStarted Oct 2015

Miami, Florida, United States

COMPLETEDNA< 1 mile

Dehydrated Human Umbilical Cord Allograft in the Management of Diabetic Foot Ulcers

NCT02844660

A Multicenter, Prospective, Randomized Controlled Comparative Parallel Study To determine the safety and effectiveness of EpiCord as compared to standard of care (SOC) therapy for the treatment of chronic, non-healing diabetic foot ulcers (DFUs)

Diabetic Foot Ulcers

MiMedx Group, Inc.130 participantsStarted Jul 2016

Birmingham, Alabama, United States • Tucson, Arizona, United States • Carlsbad, California, United States +10 more locations

COMPLETEDNA< 1 mile

Reducing Obesity Health Disparities in Hispanic Youth

NCT03943628

The proposed study will evaluate the efficacy of a family-based obesity prevention intervention in increasing physical activity and improving the quality of dietary intake among Hispanic Youth. Additional primary outcomes that will be examined include drug use and sexual risk behaviors. Secondary outcomes include examining the effects of family functioning and BMI. The knowledge expected to be gained in this study will have strong implications for prevention as well as contribute to the reduction of obesity-related health disparities seen in Hispanic youth.

OverweightFamily RelationsAdolescent Behavior+2 more

University of Miami280 participantsStarted Jan 2015

Miami, Florida, United States

COMPLETEDPhase 3< 1 mile

Renew NCP-5 for the Treatment of Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild Dementia of the Alzheimer's Type

NCT03721705

A Randomized Pivotal Study of RenewTM NCP-5 for the Treatment of Mild Cognitive Impairment due to Alzheimer's Disease or Mild Dementia of the Alzheimer's Type is a pivotal, single blind, parallel design, multi-site study intends to examine the efficacy and safety of RenewTM NCP-5 therapy in the treatment of Cognitive Impairment due to Alzheimer's Disease or Mild Dementia of the Alzheimer's Type. Subjects will be prospectively randomized to treatment or sham (in a 1:1 ratio) using stratification for Cognitive Impairment due to Alzheimer's Disease or Mild Dementia of the Alzheimer's Type, and Cardiovascular Risk (CVR) score at multiple sites. Subjects, ages 55-85, will be consented for 13 months and will receive thirty-five 60-minute RenewTM NCP-5 treatment sessions during a 7-to-12-week initial treatment period, and then transition to a lower frequency maintenance period (twice a week) for a total treatment period of 24 weeks.

Alzheimer DiseaseCognitive DysfunctionMild Cognitive Impairment+3 more

Renew Research, LLC190 participantsStarted Nov 2018

Phoenix, Arizona, United States • Irvine, California, United States • Lady Lake, Florida, United States +9 more locations

COMPLETEDPhase 27.3 miles

Evaluation of Upper GI Ulceration Induced by PL2200 Versus Aspirin in At-Risk Subjects

NCT01646814

This trial is a Phase 2, randomized, controlled study to compare the degree of mucosal injury after the oral administration of an investigational product, PL2200, and a marketed 325 mg immediate-release aspirin product.

Gastroduodenal Ulceration

PLx Pharma247 participantsStarted Sep 2012

Jupiter, Florida, United States • South Miami, Florida, United States • Towson, Maryland, United States +7 more locations

COMPLETEDPhase 28.9 miles

Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome

NCT03951077

This study will assess the potential impact of elagolix on disordered pituitary and ovarian hormones in women with polycystic ovary syndrome (PCOS).

Polycystic Ovary Syndrome

AbbVie118 participantsStarted Aug 2019

Birmingham, Alabama, United States • Mobile, Alabama, United States • San Diego, California, United States +51 more locations

COMPLETEDPhase 1/214 miles

Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With isSCC

NCT04293679

This is an open label, dose escalation study to evaluate the safety and efficacy of intralesional injection of STP705 in adult patients with Cutaneous Squamous Cell Carcinoma in situ (isSCC, Bowen's disease). The purpose of this trial is to evaluate the safety, tolerability and efficacy of various doses of STP705 administered as Intralesional injection in subjects with isSCC. Goals: * To determine the safe and effective recommended dose of STP705 for the treatment of isSCC. * Analysis of biomarkers common to isSCC formation pathway including TGF-β1 and COX-2.

Bowen's DiseaseCutaneous Squamous Cell Carcinoma in Situ

Sirnaomics25 participantsStarted Mar 2019

Aventura, Florida, United States

COMPLETEDPhase 217 miles

Study to Evaluate Exemestane With and Without Entinostat (SNDX-275) in Treatment of Postmenopausal Women With Advanced Breast Cancer

NCT00676663

The purpose of this study is to evaluate the safety and efficacy of entinostat in combination with exemestane in the treatment of advanced breast cancer.

Breast CancerEstrogen Receptor-Positive Breast CancerBreast Cancer, Estrogen Receptor-Positive+1 more

Syndax Pharmaceuticals130 participantsStarted Jun 2008

Greenbrae, California, United States • La Jolla, California, United States • La Jolla, California, United States +35 more locations

COMPLETEDPhase 242 miles

A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease

NCT03007888

Primary Objective: To compare the pharmacokinetics (PK) of single and multiple doses of IPX203 with Immediate release carbidopa-levodopa (IR CD-LD) in subjects with advanced Parkinson's disease (PD). Secondary Objectives: To compare the pharmacodynamics of single and multiple doses of IPX203 with IR CD-LD. To compare the efficacy of IPX203 with IR CD-LD following multiple doses. To evaluate the safety of IPX203.

Advanced Parkinson's Disease

Impax Laboratories, LLC28 participantsStarted Nov 2016

Little Rock, Arkansas, United States • Little Rock, Arkansas, United States • Boca Raton, Florida, United States +8 more locations

COMPLETEDPhase 2485 miles

Radiation Therapy in Treating Patients With Prostate Cancer

NCT01434290

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. Given radiation therapy in different ways may kill more tumor cells. PURPOSE: This randomized phase II trial studies radiation therapy to see how well it works in treating patients with prostate cancer.

Prostate CancerPsychosocial Effects of Cancer and Its TreatmentRadiation Toxicity+1 more

Radiation Therapy Oncology Group255 participantsStarted Sep 2011

Birmingham, Alabama, United States • Peoria, Arizona, United States • Phoenix, Arizona, United States +34 more locations

COMPLETEDPhase 3606 miles

A Study to Evaluate Efficacy and Safety of AG-348 in Not Regularly Transfused Adult Participants With Pyruvate Kinase Deficiency (PKD)

NCT03548220

Study AG348-C-006 evaluated the efficacy and safety of orally administered AG-348 as compared with placebo in participants with pyruvate kinase (PK) deficiency, who were not regularly receiving blood transfusions. Participants were randomized 1:1 to receive either AG-348 or a matching placebo.

Pyruvate Kinase DeficiencyAnemia, Hemolytic

Agios Pharmaceuticals, Inc.80 participantsStarted Aug 2018

Little Rock, Arkansas, United States • Atlanta, Georgia, United States • Indianapolis, Indiana, United States +43 more locations

TERMINATEDPhase 3705 miles

Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B

NCT01369199

The investigators evaluated the safety and efficacy of a short lead-in course (8 weeks) of entecavir followed by combination of entecavir plus peginterferon alfa-2a for 40 weeks.

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)28 participantsStarted May 2012

Los Angeles, California, United States • Los Angeles, California, United States • San Francisco, California, United States +18 more locations

COMPLETEDPhase 2967 miles

Acceptability and Performance of a Mobile Optical Biopsy Technology for Gastrointestinal Cancer Screening

NCT05396781

The investigators have a current trial in China and the US which provides significant support for the safety, cost-effectiveness, accuracy and efficiency of a high resolution microendoscope (HRME)-guided approach in the hands of experienced clinicians. To improve functionality, portability and broader use of this device by non-experts, the investigators recently developed a prototype marHRME platform with an automated, augmented reality (AR)-interpretation that provides an overlaid endoscopic + micro-endoscopic view, facilitating diagnosis and biopsy targeting.

Suspected or Known Squamous Cell NeoplasiaPrior History of Squamous Cell Dysplasia and /or Neoplasia

Anandasabapathy, Sharmila, M.D.41 participantsStarted Jan 2022

Houston, Texas, United States • São Paulo, São Paulo, Brazil

RECRUITING967 miles

CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry

NCT04688190

This multinational, investigator-initiated, retrospective study aims to investigate outcomes of patients, who underwent transcatheter mitral valve implantation (TMVI), in comparison to those screened for TMVI but deemed ineligible, who subsequently underwent interventional mitral valve edge-to-edge repair, mitral valve surgery or medical/conservative therapy.

Mitral Regurgitation

Universitätsklinikum Hamburg-Eppendorf800 participantsStarted Nov 2020

Los Angeles, California, United States • Boston, Massachusetts, United States • Houston, Texas, United States +23 more locations

COMPLETED1437 miles

Objective Pain Measurement Using a Wearable Biosensor and a Mobile Platform in Patients With Endometriosis

NCT04318275

This study aims to explore a novel objective measurement for endometriosis-related pain. A variety of pain symptoms are associated with endometriosis, including dysmenorrhea, dyspareunia, dysuria, dyschezia and chronic pelvic pain. However, a clear characterization of pain typology and topology in populations with endometriosis, other gynecologic pathology, or a normal pelvis is lacking. Understanding the precise nature of the relationship between pain and endometriosis is important for the clinical management of affected women, given the body of evidence indicating that medical and surgical management for pain associated with endometriosis has been shown to be effective. Evaluating the relationship between pain and endometriosis, however, is challenging given that pain is difficult to measure and the mechanism by which endometriosis causes pain is not well understood. While previous studies have provided important data on the incidence of pelvic pain and endometriosis, little research has been done to assess both the typology and topology of pelvic pain, pain beyond the pelvis, endometriosis diagnosis, or severity of pain using operative findings and a standardized classification system.

Biofourmis Singapore Pte Ltd.90 participantsStarted Nov 2020

Phoenix, Arizona, United States • Rochester, Minnesota, United States • Singapore, Singapore +4 more locations

PreviousPage 136 of 277Next

Heart Diseasein Miami